Latest News

Date Title Topic
27 Jul 2015 EMA Recommends a Change to the Terms of the Marketing Authorisation for Trametinib Melanoma - Anticancer agents & Biologic therapy
24 Jul 2015 ESMO Preceptorship on Prostate Cancer, Barcelona, Spain
23 Jul 2015 A Systemic Immunomodulator IMM-101 Extends Survival and Maintains Quality of Life in the IMAGE1 Study Gastrointestinal cancers - Immuno-oncology - Anticancer agents & Biologic therapy
22 Jul 2015 CheckMate of Nivolumab as Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer Lung and other thoracic tumours
17 Jul 2015 FDA Approves Gefitinib for First-Line Treatment of Patients with Metastatic NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Jul 2015 ESMO Press Release: Five Days to Decide on a Professional Life: ESMO-ESO Course on Medical Oncology for Medical Students
15 Jul 2015 Apply Now to Join the SLACOM-ESMO Clinical Trials Workshop
15 Jul 2015 EMA to Further Clarify Safety Profile of HPV Vaccines Epidemiology/Etiology/Cancer Prevention
14 Jul 2015 Researchers Call for Support for Data in the Cloud to Facilitate Genomics Research Personalised medicine - Bioethics, legal and economic issues - Translational research
13 Jul 2015 NICE’s New Symptom-based Guideline for Earlier Cancer Diagnosis Bioethics, legal and economic issues - Epidemiology/Etiology/Cancer Prevention
10 Jul 2015 NSCLC Meeting Resouces Online
Head and Neck Cancer
07 Jul 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Docetaxel Hospira UK Limited Breast cancer - Genitourinary cancers - Lung and other thoracic tumours - Head and neck cancers - Gastrointestinal cancers - Anticancer agents & Biologic therapy
06 Jul 2015 Management of Oral and Gastrointestinal Mucosal Injury